CVS HEALTH CORPORATION Cost of Revenue
CVS HEALTH CORPORATION (CVS) reported Cost of Revenue of $58.86 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-05
- CVS HEALTH CORPORATION cost of goods and services sold for the quarter ending 2026-06-30 was $58.86B, a 8.99% increase year-over-year.
- CVS HEALTH CORPORATION cost of goods and services sold for the quarter ending 2026-03-31 was $55.44B, a 8.59% increase year-over-year.
- CVS HEALTH CORPORATION cost of goods and services sold for the quarter ending 2025-12-31 was $59.06B, a 6.86% increase year-over-year.
- CVS HEALTH CORPORATION cost of goods and services sold for the quarter ending 2025-09-30 was $57.05B, a 7.74% increase year-over-year.
- CVS HEALTH CORPORATION cost of goods and services sold for fiscal 2025 was $221.17B, a 7.21% increase from fiscal 2024.
- CVS HEALTH CORPORATION cost of goods and services sold for fiscal 2024 was $206.29B, a 4.98% decline from fiscal 2023.
- CVS HEALTH CORPORATION cost of goods and services sold for fiscal 2023 was $217.10B, a 10.26% increase from fiscal 2022.
- CVS HEALTH CORPORATION cost of goods and services sold for fiscal 2022 was $196.89B, a 12.00% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $58.86B 10-Q · filed 2026-08-05 | $114.31B 10-Q · filed 2026-08-05 | $173.37B derived: sum of 3 quarters · filed 2026-08-05 | $230.41B derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2026-03-31 | $55.44B 10-Q · filed 2026-05-06 | $114.50B derived: sum of 2 quarters · filed 2026-05-06 | $171.55B derived: sum of 3 quarters · filed 2026-05-06 | $225.55B derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-12-31 | $59.06B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $116.11B derived: sum of 2 quarters · filed 2026-02-10 | $170.11B derived: sum of 3 quarters · filed 2026-08-05 | $221.17B 10-K · filed 2026-02-10 | |||
| 2025-09-30 | $57.05B 10-Q · filed 2025-10-29 | $111.05B derived: sum of 2 quarters · filed 2026-08-05 | $162.11B 10-Q · filed 2025-10-29 | $217.38B derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-06-30 | $54.01B 10-Q · filed 2026-08-05 | $105.06B 10-Q · filed 2026-08-05 | $160.33B derived: sum of 3 quarters · filed 2026-08-05 | $213.28B derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-03-31 | $51.06B 10-Q · filed 2026-05-06 | $106.33B derived: sum of 2 quarters · filed 2026-05-06 | $159.27B derived: sum of 3 quarters · filed 2026-05-06 | $209.27B derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $55.27B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $108.22B derived: sum of 2 quarters · filed 2026-02-10 | $158.21B derived: sum of 3 quarters · filed 2026-02-10 | $206.29B 10-K · filed 2026-02-10 | |||
| 2024-09-30 | $52.95B 10-Q · filed 2025-10-29 | $102.95B derived: sum of 2 quarters · filed 2025-10-29 | $151.02B 10-Q · filed 2025-10-29 | $208.44B derived: sum of 4 quarters · filed 2026-02-10 | |||
| 2024-06-30 | $50.00B 10-Q · filed 2025-07-31 | $98.07B 10-Q · filed 2025-07-31 | $155.49B derived: sum of 3 quarters · filed 2026-02-10 | $210.18B derived: sum of 4 quarters · filed 2026-02-10 | |||
| 2024-03-31 | $48.07B 10-Q · filed 2025-05-01 | $105.49B derived: sum of 2 quarters · filed 2026-02-10 | $160.18B derived: sum of 3 quarters · filed 2026-02-10 | $213.72B derived: sum of 4 quarters · filed 2026-02-10 | |||
| 2023-12-31 | $57.42B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $112.11B derived: sum of 2 quarters · filed 2026-02-10 | $165.64B derived: sum of 3 quarters · filed 2026-02-10 | $217.10B 10-K · filed 2026-02-10 | |||
| 2023-09-30 | $54.69B 10-Q · filed 2024-11-06 | $108.22B derived: sum of 2 quarters · filed 2024-11-06 | $159.68B 10-Q · filed 2024-11-06 | $211.41B derived: sum of 4 quarters · filed 2025-02-12 | |||
| 2023-06-30 | $53.54B 10-Q · filed 2024-08-07 | $104.99B 10-Q · filed 2024-08-07 | $156.72B derived: sum of 3 quarters · filed 2025-02-12 | $207.08B derived: sum of 4 quarters · filed 2025-02-12 | |||
| 2023-03-31 | $51.45B 10-Q · filed 2024-05-01 | $103.18B derived: sum of 2 quarters · filed 2025-02-12 | $153.55B derived: sum of 3 quarters · filed 2025-02-12 | $202.84B derived: sum of 4 quarters · filed 2025-02-12 | |||
| 2022-12-31 | $51.73B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $102.09B derived: sum of 2 quarters · filed 2025-02-12 | $151.38B derived: sum of 3 quarters · filed 2025-02-12 | $196.89B 10-K · filed 2025-02-12 | |||
| 2022-09-30 | $50.37B 10-Q · filed 2023-11-01 | $99.66B derived: sum of 2 quarters · filed 2023-11-01 | $145.16B 10-Q · filed 2023-11-01 | $191.54B derived: sum of 4 quarters · filed 2024-02-07 | |||
| 2022-06-30 | $49.29B 10-Q · filed 2023-08-02 | $94.80B 10-Q · filed 2023-08-02 | $141.18B derived: sum of 3 quarters · filed 2024-02-07 | $186.19B derived: sum of 4 quarters · filed 2024-02-07 | |||
| 2022-03-31 | $45.51B 10-Q · filed 2023-05-03 | $91.89B derived: sum of 2 quarters · filed 2024-02-07 | $136.90B derived: sum of 3 quarters · filed 2024-02-07 | $180.42B derived: sum of 4 quarters · filed 2024-02-07 | |||
| 2021-12-31 | $46.38B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $91.39B derived: sum of 2 quarters · filed 2024-02-07 | $134.91B derived: sum of 3 quarters · filed 2024-02-07 | $175.80B 10-K · filed 2024-02-07 | |||
| 2021-09-30 | $45.01B 10-Q · filed 2022-11-02 | $88.53B derived: sum of 2 quarters · filed 2022-11-02 | $129.43B 10-Q · filed 2022-11-02 | $171.88B derived: sum of 4 quarters · filed 2023-05-25 | |||
| 2021-06-30 | $43.52B 10-Q · filed 2022-08-03 | $84.41B 10-Q · filed 2022-08-03 | $126.87B derived: sum of 3 quarters · filed 2023-05-25 | $167.81B derived: sum of 4 quarters · filed 2023-05-25 | |||
| 2021-03-31 | $40.89B 10-Q · filed 2022-05-04 | $83.35B derived: sum of 2 quarters · filed 2023-05-25 | $124.29B derived: sum of 3 quarters · filed 2023-05-25 | $164.53B derived: sum of 4 quarters · filed 2023-05-25 | |||
| 2020-12-31 | $42.45B derived: 8-K 12 month − 10-Q 9 month · filed 2023-05-25 | $83.39B derived: sum of 2 quarters · filed 2023-05-25 | $123.63B derived: sum of 3 quarters · filed 2023-05-25 | $163.98B 8-K · filed 2023-05-25 | |||
| 2020-09-30 | $40.94B 10-Q · filed 2021-11-03 | $81.18B derived: sum of 2 quarters · filed 2021-11-03 | $121.53B 10-Q · filed 2021-11-03 | $163.59B derived: sum of 4 quarters · filed 2022-02-09 | |||
| 2020-06-30 | $40.24B 10-Q · filed 2021-08-04 | $80.59B 10-Q · filed 2021-08-04 | $122.65B derived: sum of 3 quarters · filed 2022-02-09 | $163.09B derived: sum of 4 quarters · filed 2022-02-09 | |||
| 2020-03-31 | $40.35B 10-Q · filed 2021-05-04 | $82.41B derived: sum of 2 quarters · filed 2022-02-09 | $122.85B derived: sum of 3 quarters · filed 2022-02-09 | $161.82B derived: sum of 4 quarters · filed 2022-02-09 | |||
| 2019-12-31 | $42.06B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $82.50B derived: sum of 2 quarters · filed 2022-02-09 | $121.47B derived: sum of 3 quarters · filed 2022-02-09 | $158.72B 10-K · filed 2022-02-09 | |||
| 2019-09-30 | $40.44B 10-Q · filed 2020-11-06 | $79.41B derived: sum of 2 quarters · filed 2020-11-06 | $116.65B 10-Q · filed 2020-11-06 | $157.22B derived: sum of 4 quarters · filed 2021-02-16 | |||
| 2019-06-30 | $38.97B 10-Q · filed 2020-08-05 | $76.22B 10-Q · filed 2020-08-05 | $116.78B derived: sum of 3 quarters · filed 2021-02-16 | $156.28B derived: sum of 4 quarters · filed 2021-02-16 | |||
| 2019-03-31 | $37.25B 10-Q · filed 2020-05-06 | $77.81B derived: sum of 2 quarters · filed 2021-02-16 | $117.31B derived: sum of 3 quarters · filed 2021-02-16 | $156.19B derived: sum of 4 quarters · filed 2021-02-16 | |||
| 2018-12-31 | $40.56B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $80.07B derived: sum of 2 quarters · filed 2021-02-16 | $118.94B derived: sum of 3 quarters · filed 2021-02-16 | $156.45B 10-K · filed 2021-02-16 | |||
| 2018-09-30 | $39.50B 10-Q · filed 2019-11-06 | $39.94B 10-Q · filed 2018-11-06 | $78.38B derived: sum of 2 quarters · filed 2019-11-06 | $115.88B 10-Q · filed 2019-11-06 | $118.28B 10-Q · filed 2018-11-06 | $153.56B derived: sum of 4 quarters · filed 2020-02-18 | |
| 2018-06-30 | $38.88B 10-Q · filed 2019-08-07 | $39.51B 10-Q · filed 2018-08-08 | $156.45B 8-K · filed 2019-08-08 | $78.34B 10-Q · filed 2018-08-08 | $114.06B derived: sum of 3 quarters · filed 2020-02-18 | $153.13B derived: sum of 4 quarters · filed 2020-02-18 | |
| 2018-03-31 | $37.51B 10-Q · filed 2019-05-01 | $38.83B 10-Q · filed 2018-05-02 | $75.19B derived: sum of 2 quarters · filed 2020-02-18 | $114.25B derived: sum of 3 quarters · filed 2020-02-18 | $153.01B derived: sum of 4 quarters · filed 2020-02-18 | ||
| 2017-12-31 | $37.68B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $76.75B derived: sum of 2 quarters · filed 2020-02-18 | $115.50B derived: sum of 3 quarters · filed 2020-02-18 | $153.45B 10-K · filed 2020-02-18 | |||
| 2017-09-30 | $39.06B 10-Q · filed 2018-11-06 | $77.82B derived: sum of 2 quarters · filed 2018-11-06 | $115.77B 10-Q · filed 2018-11-06 | ||||
| 2017-06-30 | $38.76B 10-Q · filed 2018-08-08 | $76.70B 10-Q · filed 2018-08-08 | |||||
| 2017-03-31 | $37.94B 10-Q · filed 2018-05-02 | ||||||
| 2016-12-31 | $146.53B 8-K · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |